This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hoffmann-La Roche Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Philipp Tropberger: Innovator in Oligonucleotide Research
Introduction
Philipp Tropberger is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of molecular biology, particularly in the modulation of gene expression.
Latest Patents
Tropberger holds a patent titled "Oligonucleotides for Modulating RTEL1 Expression." This innovative work focuses on the development of oligonucleotides that can influence the expression of the RTEL1 gene, which is crucial for various biological processes.
Career Highlights
Philipp Tropberger is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His work at this esteemed organization has allowed him to advance his research and contribute to groundbreaking developments in biotechnology.
Collaborations
Throughout his career, Tropberger has collaborated with esteemed colleagues, including Brian Leonard and Lykke Pedersen. These partnerships have fostered a collaborative environment that enhances the potential for innovative discoveries.
Conclusion
Philipp Tropberger's contributions to the field of oligonucleotide research exemplify the impact of innovative thinking in biotechnology. His work continues to pave the way for advancements in gene modulation and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile